Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 331

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk

Open access
Koenig, Gerald, Seneff, Stephanie·2015·Disease Markers

Abstract

Gamma-glutamyltransferase (GGT) is a well-established serum marker for alcohol-related liver disease. However, GGT’s predictive utility applies well beyond liver disease: elevated GGT is linked to increased risk to a multitude of diseases and conditions, including cardiovascular disease, diabetes, metabolic syndrome (MetS), and all-cause mortality. The literature from multiple population groups worldwide consistently shows strong predictive power for GGT, even across different gender and ethnic categories. Here, we examine the relationship of GGT to other serum markers such as serum ferritin (SF) levels, and we suggest a link to exposure to environmental and endogenous toxins, resulting in oxidative and nitrosative stress. We observe a general upward trend in population levels of GGT over time, particularly in the US and Korea. Since the late 1970s, both GGT and incident MetS and its related disorders have risen in virtual lockstep. GGT is an early predictive marker for atherosclerosis, heart failure, arterial stiffness and plaque, gestational diabetes, and various liver diseases, including viral hepatitis, other infectious diseases, and several life-threatening cancers. We review literature both from the medical sciences and from life insurance industries demonstrating that serum GGT is a superior marker for future disease risk, when compared against multiple other known mortality risk factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1155/2015/818570

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 81 references

Research works printed but not linked: 19

  1. 10.1016/j.ab.2011.03.026 · doi:10.1016/j.ab.2011.03.026
  2. 10.1155/2014/376518 · doi:10.1155/2014/376518
  3. 10.1034/j.1600-0609.2002.01636.x · doi:10.1034/j.1600-0609.2002.01636.x
  4. 10.1158/0008-5472.can-07-6686 · doi:10.1158/0008-5472.can-07-6686
  5. 1974, Annals of Clinical & Laboratory Science, 4, 13
  6. 10.1016/j.atherosclerosis.2012.10.059 · doi:10.1016/j.atherosclerosis.2012.10.059
  7. 10.1515/cclm.2009.197 · doi:10.1515/cclm.2009.197
  8. 10.2460/javma.235.2.194 · doi:10.2460/javma.235.2.194
  9. 10.1093/infdis/jiu088 · doi:10.1093/infdis/jiu088
  10. 10.3390/v6114666 · doi:10.3390/v6114666
  11. 10.1111/j.1742-7843.2005.pto_97103.x · doi:10.1111/j.1742-7843.2005.pto_97103.x
  12. 10.1155/2015/741731 · doi:10.1155/2015/741731
  13. 2014, Acta Medica Iranica, 52, 385
  14. 2004, Journal of Pharmacy and Pharmaceutical Sciences, 7, 274
  15. 2012, Journal of Insurance Medicine, 43, 162
  16. 10.1007/s00277-009-0718-6 · doi:10.1007/s00277-009-0718-6
  17. 10.5152/tjg.2014.3693 · doi:10.5152/tjg.2014.3693
  18. 10.1017/s1368980012000808 · doi:10.1017/s1368980012000808
  19. 10.1097/MD.0000000000001249 · doi:10.1097/md.0000000000001249

Cited by

See all 331

Metadata

Authors
Koenig, G., & Seneff, S.
Venue
Disease Markers
Publisher
Wiley
Published
2015
Volume
2015
Pages
1-18
ISSN
  • 0278-0240 (ISSN-L)
  • 1875-8630
OpenAlex
W1929620983
Cited by
331
References
81
FWCI
9.68
Type
journal article
Language
en
Open access
hybrid
Funders
Quanta Computers, Taipei, Taiwan

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk. https://app.cochat.ai/papers/10.1155/2015/818570
The paper
Koenig, G., & Seneff, S. (2015). Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk. Disease Markers. https://doi.org/10.1155/2015/818570

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.